Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Clinical trial NCT03399552 · COMPLETED
Trial details
- NCT number
- NCT03399552
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2023-01-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.